Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis

Journal of Infection

Volumn 68, Issue 5, 2014, Pages 467-477

  Selvaggi, Carla ^a   Pierangeli, Alessandra ^a   Fabiani, Marco ^a   Spano, Lucia ^a   Nicolai, Ambra ^b   Papoff, Paola ^b   Moretti, Corrado ^b   Midulla, Fabio ^b   Antonelli, Guido ^a   Scagnolari, Carolina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bronchiolitis; HRV; IFN lambda; IL 28; IL 29; ISG56; MxA; RSV; Viral load

Indexed keywords

INTERFERON; INTERFERON LAMBDA 3; INTERLEUKIN 28A; INTERLEUKIN 29; UNCLASSIFIED DRUG; IL28A PROTEIN, HUMAN; IL28B PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; INFANT; INTERFERON STIMULATED GENE; INTERFERON STIMULATED GENE 56 GENE; MAJOR CLINICAL STUDY; MALE; MIXOVIRUS RESISTANCE A GENE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SCORING SYSTEM; VIRAL BRONCHIOLITIS; VIRUS GENE; VIRUS IDENTIFICATION; BRONCHIOLITIS; COMPARATIVE STUDY; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NASOPHARYNX; PATHOLOGY; PICORNAVIRUS INFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SEVERITY OF ILLNESS INDEX; VIROLOGY;

BRONCHIOLITIS; FEMALE; HUMANS; INFANT; INTERLEUKINS; MALE; NASOPHARYNX; PICORNAVIRIDAE INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RHINOVIRUS; SEVERITY OF ILLNESS INDEX;

EID: 84897962352     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.12.010     Document Type: Article

References (59)

1. Garibaldi B.T., Illei P., Danoff S.K. Bronchiolitis. Immunol Allergy Clin North Am 2012, 4:601-619.
2. Mullins J.A., Lamonte A.C., Bresee J.S., Anderson L.J. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J 2003, 22:857-862.
3. Fitzgerald D.A. Viral bronchiolitis for the clinician. J Paediatr Child Health 2011, 4:160-166.
4. Midulla F., Scagnolari C., Bonci E., Pierangeli A., Antonelli G., De Angelis D., et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 2010, 95:35-41.
5. Friedlander S.L., Busse W.W. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005, 116:267-273.
6. Arden K.E., Mackay I.M. Newly identified human rhinoviruses: molecular methods heat up the cold viruses. Rev Med Virol 2010, 20:156-176.
7. Bont L. Current concepts of the pathogenesis of RSV bronchiolitis. Adv Exp Med Biol 2009, 634:31-40.
8. Bont L., Ramilo O. The relationship between RSV bronchiolitis and recurrent wheeze: the chicken and the egg. Early Hum Dev 2011, 87(Suppl. 1):S51-S54.
9. Halfhide C., Smyth R.L. Innate immune response and bronchiolitis and preschool recurrent wheeze. Paediatr Respir Rev 2008, 9:251-262.
10. González P.A., Bueno S.M., Carreño L.J., Riedel C.A., Kalergis A.M. Respiratory syncytial virus infection and immunity. Rev Med Virol 2012, 22:230-244.
11. Jacobs S.E., Lamson D.M., St George K., Walsh T.J. Human rhinoviruses. Clin Microbiol Rev 2013, 26:135-162.
12. Scagnolari C., Antonelli G. Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C. Expert Opin Biol Ther 2013, 5:693-711.
13. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003, 4:63-68.
14. Sommereyns C., Paul S., Staeheli P., Michiels T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells invivo. PLoS Pathog 2008, 4:e1000017.
15. Ank N., Iversen M.B., Bartholdy C., Staeheli P., Hartmann R., Jensen U.B., et al. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 2008, 180:2474-2485.
16. Mordstein M., Kochs G., Dumoutier L., Renauld J.C., Paludan S.R., Klucher K., et al. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 2008, 4:e1000151.
17. Khaitov M.R., Laza-Stanca V., Edwards M.R., Walton R.P., Rohde G., Contoli M., et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 2009, 64:375-386.
18. Okabayashi T., Kojima T., Masaki T., Yokota S., Imaizumi T., Tsutsumi H., et al. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 2011, 160:360-366.
19. Mordstein M., Neugebauer E., Ditt V., Jessen B., Rieger T., Falcone V., et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 2010, 84:5670-5677.
20. Scagnolari C., Midulla F., Riva E., Monteleone K., Solimini A., Bonci E., et al. Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis. Virus Res 2012, 165:236-240.
21. Wilson J., Rowlands K., Rockett K., Moore C., Lockhart E., Sharland M., et al. Genetic variation at the IL 10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. J Infect Dis 2005, 191:1705-1709.
22. Pierangeli A., Gentile M., Di Marco P., Pagnotti P., Scagnolari C., Trombetti S., et al. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J Med Virol 2007, 79:463-468.
23. Pierangeli A., Scagnolari C., Trombetti S., Grossi R., Battaglia M., Moretti C., et al. Human bocavirus infection in hospitalized children in Italy. Infuenza Other Respi Viruses 2008, 2:175-179.
24. Peret T.C., Hall C.B., Schnabel K.C., Golub J.A., Anderson L.J. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 1998, 79:2221-2229.
25. Kiang D., Kalra I., Yagi S., Louie J.K., Boushey H., Boothby J., et al. Assay for 5' noncoding region analysis of all human rhinovirus prototype strains. J Clin Microbiol 2008, 46:3736-3745.
26. Scagnolari C., Midulla F., Pierangeli A., Moretti C., Bonci E., Berardi R., et al. Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin Vaccine Immunol 2009, 16:816-823.
27. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A.B., Bartlett N.W., et al. Role of deficient type III interferon-λ production in asthma exacerbations. Nat Med 2006, 12:1023-1026.
28. Scagnolari C., Midulla F., Selvaggi C., Monteleone K., Bonci E., Papoff P., et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol 2012, 201:311-317.
29. Tapparel C., Cordey S., Van Belle S., Turin L., Lee W.-M., Regamey N., et al. New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J Clin Microbiol 2009, 47:1742-1749.
30. Hu A., Colella M., Tam J.S., Rappaport R., Cheng S.M. Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J Clin Microbiol 2003, 41:149-154.
31. Jewell N.A., Cline T., Mertz S.E., Smirnov S.V., Flaño E., Schindler C., et al. Lambda interferon is the predominant interferon induced by influenza A virus infection invivo. J Virol 2010, 84:11515-11522.
32. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005, 289:G960-G968.
33. Spann K.M., Tran K.C., Chi B., Rabin R.L., Collins P.L. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 2004, 78:4363-4369.
34. Scagnolari C., Midulla F., Trombetti S., Pierangeli A., Tromba V., Grossi R., et al. Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis. Exp Biol Med 2007, 232:1355-1359.
35. García C., Soriano-Fallas A., Lozano J., Leos N., Gomez A.M., Ramilo O., et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J 2012, 3:86-89.
36. Jartti T., Paul-Anttila M., Lehtinen P., Parikka V., Vuorinen T., Simell O., et al. Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study. Respir Res 2009, 10:85.
37. Midulla F., Pierangeli A., Cangiano G., Bonci E., Salvadei S., Scagnolari C., et al. Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up. Eur Respir J 2012, 39:396-402.
38. Baraldo S., Contoli M., Bazzan E., Turato G., Padovani A., Marku B., et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol 2012, 130:1307-1314.
39. Miller E.K., Hernandez J.Z., Wimmenauer V., Shepherd B.E., Hijano D., Libster R., et al. A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med 2012, 185:508-516.
40. Piralla A., Lilleri D., Sarasini A., Marchi A., Zecca M., Stronati M., et al. Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008-2009. Diagn Microbiol Infect Dis 2012, 73:162-167.
41. Iwane M.K., Prill M.M., Lu X., Miller E.K., Edwards K.M., Hall C.B., et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011, 204:1702-1710.
42. Pierangeli A., Ciccozzi M., Chiavelli S., Concato C., Giovanetti M., Cella E., et al. Molecular epidemiology and genetic diversity of human rhinovirus affecting hospitalized children in Rome. Med Microbiol Immunol 2013, 202(4):303-311.
43. Linder J.E., Kraft D.C., Mohamed Y., Lu Z., Heil L., Tollefson S., et al. Human rhinovirus C: age, season, and lower respiratory illness over the past 3 decades. J Allergy Clin Immunol 2012, 131:69-77.
44. Bermejo-Martin J.F., Tenorio A., Ortiz de Lejarazu R., Eiros J.M., Matías V., Dominguez G.M., et al. Similar cytokine profiles in response to infection with respiratory syncytial virus type A and type B in the upper respiratory tract in infants. Intervirology 2008, 51:112-115.
45. Sheeran P., Jafri H., Carubelli C., Saavedra J., Johnson C., Krisher K., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999, 18:115-122.
46. Noah T.L., Ivins S.S., Murphy P., Kazachkova I., Moats-Staats B., Henderson F.W. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin Immunol 2002, 104:86-95.
47. Jordan W.J., Eskdale J., Boniotto M., Rodia M., Kellner D., Gallagher G. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29). Genes Immun 2007, 8:13-21.
48. Pekarek V., Srinivas S., Eskdale J., Gallagher G. Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun 2007, 8:177-180.
49. Dai J., Megjugorac N.J., Gallagher G.E., Yu R.Y., Gallagher G. IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood 2009, 113:5829-5838.
50. Francois-Newton V., Magno de Freitas A.G., Payelle-Brogard B., Monneron D., Pichard-Garcia L., Piehler J., et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response. PLoS One 2011, 6:e22200.
51. Wang Q., Miller D.J., Bowman E.R., Nagarkar D.R., Schneider D., Zhao Y., et al. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog 2011, 7(5):e1002070.
52. Papoff P., Moretti C., Cangiano G., Bonci E., Roggini M., Pierangeli A., et al. Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis. Acta Paediatr 2011, 100:17-23.
53. Phipps S., Lam C.E., Mahalingam S., Newhouse M., Ramirez R., Rosenberg H.F., et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 2007, 110:1578-1786.
54. Edwards M.R., Regamey N., Vareille M., Kieninger E., Gupta A., Shoemark A., et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 2013, 6:797-806.
55. Lo M.S., Brazas R.M., Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 2005, 79(14):9315-9319.
56. Grandvaux N., Servant M.J., TenOever B., Sen G.C., Balachandran S., Barber G.N., et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 2002, 76:5532-5539.
57. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13:539-548.
58. Servant M.J., Grandvaux N., Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 2002, 64:985-992.
59. Tregoning J.S., Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010, 23(1):74-98.